- Home
- SUPN vs OFG Comparison
SUPN vs OFG Comparison
Compare SUPN & OFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- OFG
- Stock Information
- Founded
- SUPN 2005
- OFG 1964
- Country
- SUPN United States
- OFG United States
- Employees
- SUPN N/A
- OFG N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- OFG Major Banks
- Sector
- SUPN Health Care
- OFG Finance
- Exchange
- SUPN Nasdaq
- OFG Nasdaq
- Market Cap
- SUPN 1.9B
- OFG 2.0B
- IPO Year
- SUPN 2012
- OFG N/A
- Fundamental
- Price
- SUPN $35.57
- OFG $43.77
- Analyst Decision
- SUPN Hold
- OFG Buy
- Analyst Count
- SUPN 1
- OFG 2
- Target Price
- SUPN $36.00
- OFG $47.50
- AVG Volume (30 Days)
- SUPN 422.4K
- OFG 347.0K
- Earning Date
- SUPN 11-04-2024
- OFG 10-16-2024
- Dividend Yield
- SUPN N/A
- OFG 2.29%
- EPS Growth
- SUPN 130.79
- OFG 8.35
- EPS
- SUPN 1.07
- OFG 4.13
- Revenue
- SUPN $651,972,000.00
- OFG $639,464,000.00
- Revenue This Year
- SUPN $7.82
- OFG N/A
- Revenue Next Year
- SUPN N/A
- OFG $1.02
- P/E Ratio
- SUPN $33.25
- OFG $10.60
- Revenue Growth
- SUPN 6.79
- OFG 2.17
- 52 Week Low
- SUPN $25.53
- OFG $32.96
- 52 Week High
- SUPN $39.37
- OFG $47.57
- Technical
- Relative Strength Index (RSI)
- SUPN 53.46
- OFG 54.34
- Support Level
- SUPN $35.87
- OFG $40.00
- Resistance Level
- SUPN $39.37
- OFG $45.64
- Average True Range (ATR)
- SUPN 1.69
- OFG 1.22
- MACD
- SUPN 0.03
- OFG 0.35
- Stochastic Oscillator
- SUPN 36.03
- OFG 56.52
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About OFG OFG Bancorp
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. It provides services in the region of Puerto Rico.